Carvykti

ciltacabtagene autoleucel · Janssen Biotech, Inc. (in collaboration with Legend Biotech Corporation)

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Carvykti, covering 2025-06-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel [Phase 2]